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1 Report Summary 
Keltoi is a therapeutic residential facility within the Eastern region of the Health
Service Executive (HSE) that uses an innovative systemic model to provide an 8
week rehabilitation programme for former drug users. This report describes the
results of a follow-up evaluation survey of 94 successive clients who attended the
programme and who were between 1-and 3-years post-discharge. 
100 attendees of the Keltoi programme who were (minimum) 1-year post-
completion of the residential component of their treatment agreed to take part
in the study, whereby the four page Maudsley Addiction Profile (MAP) was
completed, as was a short qualitative interview. The cohort was recruited on a
temporal basis; the first study participant was discharged on 18 November
2002, the one hundredth was discharged on 30 August 2004. This is a non-
random cross-sectional field-study of a sample of 67% (100/150) of the total
number of Keltoi clients to that date.
Of the 80 clients on whose responses analysis was carried out, 51% were
abstinent from all illicit drugs and alcohol in 30 days pre-interview; 60% were
abstinent from all illicit drugs but had consumed alcohol in the 30 day
preinterview period; and 65% were abstinent from all substances excluding
alcohol and cannabis in the same period. Of the 40% of individuals who were
using substances other than alcohol, only five (5.4%) were injecting drugs. 
Cross-sectional outcomes are also presented with respect to crime, health and
risk behaviours, social and personal functioning and employment. In general,
abstinent clients (including those who were abstinent excluding alcohol)
reported minimal criminal activity and positive outcomes in relation to the
other measures. 
2 Introduction to Evaluation Project 
Keltoi’s approach remains unique in Ireland; its chosen model is based on the
finding that rehabilitation with a focus on living skills rather than insight
produces more favourable outcomes (Mesa Grande [42]), where a favourable
outcome sees clients developing and successfully maintaining a drug free
lifestyle. 
However, with the pursuit of favourable outcomes in mind, it has always been
understood that the Keltoi philosophy will be determined by what works,
rather than allegiance to any particular treatment modality. Naturally, this
means that ongoing research and evaluation are essential. It was envisaged
from the inception of the project that formal client feedback would be actively
sought and that the policies and procedures in use would be reviewed on an
ongoing basis. 
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The purpose of this evaluation process is to identify and develop the elements of
the Keltoi philosophy that maximise clients’ opportunities to develop a drug-free
lifestyle, while reconsidering those aspects seen as less useful. As part of this process,
intensive clinical and management supervision involving use of video taping for
clinical best practice and training are in use. Staff and residents continue to actively
contribute to this evaluation and residents’ files are available to them to read and
comment on. To date, the formal client feedback involves an outcomes analysis
using the Maudsley Addiction Profile (MAP), a brief, structured interview for
treatment outcome research, and a short, qualitative internally-designed
questionnaire. Interviews were carried out with recruited clients between 1-and 3-
years after they left Keltoi, regardless of whether they had completed the
programme. 
Like Keltoi itself, the concept of evaluation from the outset of a project of this
nature is progressive and thus it is unfortunate that Keltoi cannot directly compare
the results of its client survey with similar studies conducted on or by treatment
centres with different aligned philosophies. Nonetheless, some general conclusions
may be drawn and there is scope to review the results of the Keltoi study in the
context of other, not directly comparable, but related studies, including ROSIE [47]
and ATOS [53][15]. These studies have a common aim of evaluating the
effectiveness of different treatment and rehabilitation modalities for dependent
drug-users. 
3 History & Philosophy of Keltoi 
Capture re-capture studies [12][34] to measure prevalence of drug use in Ireland have
estimated the opiate using population at approximately 14,000 over the period 1996
to 2001. In the meantime, the reports of the National Drug Treatment Reporting
System (NDTRS) [35] make it clear that increasing numbers of individuals are seeking
treatment for opiate addiction. 
This study into a new residential rehabilitation programme is timely. The National
Drug Strategy of 2001 set targets for data collection, treatment, and supply reduction.
The mid-term review has now clearly seen the importance of rehabilitation and has
expanded the strategy to incorporate rehabilitation as the fifth pillar. 
Keltoi opened its doors in February 2001 as a research and residential therapeutic
project with the goal of providing a facility for opiate users over the age of sixteen
who want to realise and maintain a drug-free lifestyle. Located in the grounds of St.
Mary’s Hospital in the Phoenix Park, Dublin and funded by the then Eastern
Regional Health Authority (ERHA), its unique service delivery is based on a systemic
approach to addiction [29]. This approach depends on the belief system of the client
rather than the belief system of the treatment provider; clients develop their own care
plan and there is a great deal of equality between clients and staff. 
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The actual therapeutic work is primarily cognitive behavioural [11] and occurs
throughout all aspects of living in Keltoi. This focuses on cognitive, affective and
external stimuli that trigger substance misuse episodes.
The programme is over an eight-week period with a strong emphasis on
occupational work. Evidence suggests that occupational conditions are associated
with self-esteem [22][9], but these circumstances also provide opportunities to
investigate individual relapse factors for prevention within a realistic framework
using a Relapse Prevention approach [16][33]. The essence of all activities at Keltoi
is therapeutic; advocating respect, life management and negotiating around
interpersonal relationships, in the context of groups. 
Prior to admission, clients need to be drug-free, physically stable and committed to
remaining drug-free while resident at Keltoi. Keltoi is an environment where as an
organisation and as a therapeutic space every effort is made to implement many of
the principles of Anderson and Goolishian’s “not-knowing approach” [4][5], or as
it is more recently referred to, a “collaborative language systems approach” [3]. 
There is a total of 18 staff at Keltoi, including counsellors, residential care-workers,
a cooking instructor, a fitness instructor, an administrator and a manager2, whose
role includes clinical and management duties. There are 20 beds in the centre, but
only 8 of these are currently utilised, due to the full staff complement not being
deployed. The staff members, by design, are from a variety of different backgrounds
and many do not have prior experience of addiction treatment and rehabilitation;
this diversity was an expressed wish of those setting up the project, the purpose
being to obtain a multiplicity of perspectives. 
Dual-diagnosis patients are able to access a place in the programme and are likely
to have been on psychotropic medication for depression and/or psychotic illness.
Neuroleptics and anti-depressants are the only psychotropic medications that are
permitted. 
Clients who join the Keltoi programme are verifiably drug-free (including
prescribed substitute drugs) for a period prior to their arrival as part of the
recruitment process, thus all clients can be considered to be abstinent at the
beginning of their stay. A large proportion of Keltoi clients (50%) are referred from
detoxification centres and Bobby Smyth et al. have published research on the
characteristics of the individuals who attend these centres [51][52]. 95% of the
client group in these papers had severe opiate dependence problems for many  
years and a small proportion had severe cocaine dependence. It is highly
appropriate that clients detoxify before starting the programme, as the Keltoi
approach depends on clients developing their own care plan and living skills. The
Keltoi assessment process usually takes between 10 days and 3 weeks unless a
problem arises. 
___________________________
2A literacy instructor is employed on a sessional basis and an art therapist was employed on a part-
time basis for much of the study period. 
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4 Methodology 
4.1   Study Design
100 Keltoi clients agreed to take part in the study. This entailed participating in a
15 minute interview between 1-and 3-years post-completion of the residential
component of their Keltoi programme. At this interview, the 4-page Maudsley
Addiction Profile (MAP) [36] was completed, as was a short qualitative
questionnaire. The MAP is a brief, structured interview for treatment outcome
research. It was first published in 1998 and is intended for use as a core research
instrument; a resource for treatment services wishing to undertake outcome
studies. 
The cohort was recruited on a temporal basis; the first study participant completed
the programme and went to live in the community on 18 November 2002, the
hundredth was discharged on 30 August 2004. This is a cross-sectional cohort
sample of approximately 67% of the total number of Keltoi clients admitted to the
programme by that date. Starting in September 2002, each successive client
arriving in Keltoi was requested to take part in the evaluation study. No clients
declined to take part in the study at the recruitment phase and no clients were
excluded from the recruitment process (the only criterion for study eligibility was
to be starting a new treatment episode in Keltoi). The recruitment process ended
in July 2004, by which time a sample of 100 individuals was obtained, each of
whom was allocated a unique client identification number and signed a consent
form. These individuals left contact details with Keltoi on their departure and
knew that they would be contacted at least one year following their departure to
take part in the evaluation interview. Keltoi clients are sixteen years of age and
over; participation in the study was entirely voluntary; full consent was obtained
as part of the recruitment process and ethical approval was in place. It was not a
recruitment requirement that clients finish the Keltoi programme. No
remuneration was offered for participation in the study. Questionnaires are
identified by a number only and clients’ contact details are stored separately, thus
the surveys are effectively anonymous for analysis purposes. Completed
questionnaires were returned to an investigator within the Health Service
Executive (HSE) who was not part of the Keltoi team. The interview process began
in May 2004 and the final interview took place in July 2006. Prior to interview,
Keltoi contacted the individual clients to confirm that consent was still in place,
however, follow-up and interviewing of study participants was carried out
independently of Keltoi by the Rehabilitation and Integration Service (RIS) in
the Northern Area Health Board Addiction Service. All interviewers were trained
in the correct procedure for completion of the MAP. The MAP is a well-validated,
self-reporting instrument that has been extensively field tested [36].
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Although 100 clients were recruited, it was decided that 6 members of that
sample who attended Keltoi twice within the recruitment period, would be
interviewed once only in relation to their Keltoi experience. Thus the total
recruited to the study is 94 clients. Two of these clients died pre-interview
(mortality rate 2/94 = 2.13%). 
Analysis was carried out on 80 completed questionnaires; Table 1 shows the
follow-up status for the full cohort of 94 individuals. Of these 80
questionnaires, 52 respondents were male, 18 were female and 10 did not
have a client gender associated with them. 
All interviews took place at least one year after discharge from Keltoi and 80%
were verifiably completed within three years of the clients’ discharge dates. A
tender was issued in October 2006 seeking an external consultant to enter the
data, perform statistical analysis and produce a report describing the results of
the study. 
Table 1: Follow-up
Key outcome measures include drug use, criminal involvement, general health,
sexual behaviour, employment and social functioning. Measures were taken for
the 30 day pre-interview period. Dependent drug use is a chronic, relapsing
condition [38], therefore applying abstinence as a marker of success is to
evaluate drug treatment at its highest level. Where the word “abstinent” is used
without qualification, it means that the client is abstinent from all substances
including alcohol, cannabis and substitute prescription drugs. 
Descriptive statistics were computed for the entered data and frequency
analyses were carried out. Missing data and invalid answers are excluded from
the analyses on a question by question basis. Results are presented in tabular
form, with percentages rounded to the nearest percent and where “n” denotes
numbers of individuals.
Status % n
Successful interview 85.1 80 
Interviewed outside timeframe 1.1 1 
Not traced 7.4 7 
Traced but not interviewed 4.3 4 
Believed deceased 2.1 2 
Total 100 94
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4.2   Data Entry & Verification 
The data was entered to the statistical software package SPSS 12.0. Two types
of visual accuracy inspection were used following data entry: one sorted the
data into columns and looked for discrepancies and the other involved a full
comparison of the data from each questionnaire against the corresponding
datapoint in the dataset. The database consists of 190 variables for each of 80
clients 15,200 datapoints in all. The initial data entry error rate was less than
0.5%.
Table 2: Keltoi Admission Record
5 Results
Of the 485 documented client assessments from Keltoi’s opening until July 2004
(when the last study participant was recruited), 30.9% (150 clients)3 were accepted to
the programme; 1 person declined to attend following successful completion of the
referral process. 
Table 2 shows the admission record. 149 clients out of 482 referrals were admitted to
Keltoi. “Client/referrer did not proceed” includes clients who relapsed following
referral, thus did not fully undergo the assessment process and therefore were not in
a position to present for admission: the total number of these is 253 out of 482
referrals. Where clients completed the assessment process but were not accepted 
___________________________
3Some clients have attended Keltoi on more than one occasion. They received separate
client ID numbers for each admission. 
Reason % n 
Admitted 30.7 149 
Not accepted 6 29 
Client/referrer did not proceed 52.2 253 
Positive urines 9.7 47 
Insuficient information 0.8 4 
SubTotal 99.4 482 
Allocated ID not linked to client 0.6 3 
Total 100 485 
9Keltoi Client Evaluation Study
to the programme, either Keltoi was deemed to be unsuitable for their needs at
the time of assessment or they failed an element of the assessment process other
than submission of drug-free urine samples: this comprises 29 out of 482
referrals. 
Of the 100 clients who agreed to take part in the study, 28 were female and 72
were male. 4 men were recruited twice and 2 women were recruited twice; thus
the sample size of 94 individuals is made up of 68 men and 26 women. Two of
these clients died pre-interview (mortality rate 2/94 = 2.13%). 
Table 3: Completion by Gender
Table 3 clearly shows that completion rates are the same for members of each
gender. However, in line with what has been observed in international studies
[20], Keltoi has had more males present for treatment than females, in a ratio of 
7:3. This ratio is also observed in the Keltoi Evaluation Sample: Males 68/94 =
72%, Females 26/94 = 28%.
Of the 80 clients who successfully completed an interview, 80% (64 clients) could
be verified to have given an interview between 1-and 3-years following their
discharge. The mean time at which an interview took place post-discharge was
1.9 years (mode = 1.6 years, median = 1.8 years). 
% n
Male (n=52)
Yes 83 43 
No 17 9
Total 100 52
Female (n=18) 
Yes 83 15 
No 17 3
Total 100 18 
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Table 4: Completion & Abstinence
Table 5: Completion & Abstinence Excluding Alcohol
The earliest that an interview took place was 1.2 years post-discharge and the
latest was 3 years. 52 of these clients are men, 18 are women and the remaining
10 questionnaires do not have a client gender associated with them. 
Note that the 4 people who are abstinent but did not complete the Keltoi
programme (Table 4) could coincide with individuals who were recruited twice
and completed one treatment episode but not the other(s). 
Table 6: Abstinence in Past 30 Days
Yes       No     Total
% n % n % n
Abstinence  Yes 41.5 29 5.5 4 47 33 
No 41.5 29 11.5 8 53 37 
Total 83 58 17 12 100 70 
Completion
Yes       No     Total
% n % n % n
Abstinence  Yes 51.5 36 6.0 4 57.5 40 
No 31.5 22 11.0 8 42.5 30 
Total 83 58 17 12 100 70 
Completion
Abstinent % n 
Yes 51 41 
No 49 39 
Total 100 80
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5.1   Abstinence Results 
Table 6 shows the levels of abstinence from all substances including alcohol in
the last 30 days (n=80). Table 7 shows the levels of abstinence for each gender
in the last 30 days (n=70)4 .
Table 7: Abstinence by Gender
While no clients were abstinent from all substances excluding cannabis, a
proportion of clients were abstinent from all substances apart from alcohol and
cannabis: these figures are shown in Table 9. 
Table 8: Abstinence, Excluding Alcohol, in Past 30 Days 
Table 9: Abstinence, Excluding Alcohol & Cannabis, in Past 30 Days
___________________________
4This analysis is conducted only on the clients for whom gender data is available. 
Abstinent Exc. Alcohol % n 
Yes 60 48 
No 40 32 
Total 100 80
Abstinent Exc. Alcohol & Canabis % n
Yes 65 52 
No 35 28 
Total 100 80
% n
Male (n=52)
Yes 50 26 
No 50 26 
Total 100 52
Female (n=18) 
Yes 39 7
No 61 11 
Total 100 18 
12 Keltoi Client Evaluation Study
5.1.1   Alcohol & Cannabis Consumption 
Of the 7 clients who are abstinent excluding alcohol, two are women, each of
whom consumed alcohol on two days only within the last 30 and did not exceed
the recommended 14 units of alcohol/week. Of the five men, each reported
consumption of approximately 24 units per week within the last 30 days: the
recommended limit for men is 21 units per week or less. The further 4 clients who
consumed alcohol and cannabis in the last thirty days, 1 was female, 3 were male
and they were smoking/eating cannabis daily or six days a week. 1 of the men
reported alcohol consumption significantly in excess of the recommended weekly
limit, the others were within or just outside the recommended levels. 
5.2   Crime Results
6 clients (7.5%) of the full cohort (n=80) sold drugs in the past 30 days. 5 of these
clients are male. 2 clients (1 male, 1 female) are selling drugs on average 10 
Table 10: Crime Committed in Past 30 Days -All Clients
Table 11: Crime Committed in Past 30 Days -Abstinent Clients
Table 12: Crime Committed in Past 30 Days -Clients 
Abstinent Excluding Alcohol 
Crime Committed % n 
Yes 22.5 18 
No 77.5 62 
Total 100 80
Crime Committed % n
Yes 15 6 
No 85 35 
Total 100 41
Crime Committed % n
Yes 12.5 6
No 87.5 42 
Total 100 48
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times per day. The mean number of times that drugs are being sold on a typical
day in the 30 days is 8.25 (median 8.25, mode 10). The standard deviation is 6.9,
the minimum is once daily and the maximum is 20 times daily (1 client only).
None of the abstinent cohort are selling drugs, nor are any of those who are
abstinent excluding alcohol. 
Clients using drugs including cannabis did not report purchase or consumption 
Table 13: Crime Committed in Past 30 Days by Gender 
of those drugs when answering the questions on crime5 . Tables 10-13 show
reported crime figures. The number of crimes committed per client is considered
to be the number of days on which a crime was committed multiplied by the
number of times that crime was committed on a particular day.
5.2.1   Number of Crimes Committed Per Client -All Clients 
The mean number of crimes per client (n=78) was 10, the median and the mode
number of crimes was zero. However, the standard deviation was 37.4 and the
number of crimes ranged from zero to 240 crimes committed in the past 30
days. The total number of crimes committed by this cohort was 788 in the past
30 days. Nonetheless, the majority of clients (77.5%) committed no crimes. No
theft from or of vehicles was reported. 2 people (2.5%) reported overall property
theft; 1 on 2 days, 1 on 1 day. 2 people (2.5%) committed a crime not described
above; 1 person committed criminal damage on 1 day, the other bought a stolen
article on 1 day. 3 people (3.8%) shoplifted daily, 3 people (3.8%) shoplifted on
1 day only and 1 person shoplifted on 2 days. 
___________________________
5This has been observed in other studies including ROSIE.
% n
Male (n=52)
Yes 25 13 
No 75 39 
Total 100 52
Female (n=18) 
Yes 17 3 
No 83 15 
Total 100 18 
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Fraud/forgery was committed by 3 people (3.8%); 1 person (1.3%) reported daily
fraud/forgery, the others reported 3 days and 2 days respectively. 6 people (7.6%)
reported selling drugs; 1 person on 2 days only, 2 people once a week, 1 person
twice a week, 1 person three times a week and 1 person four times a week. Of
the two individuals who committed the most crimes, one was selling drugs
three times a week on average 10 times a day and was shoplifting twice daily,
the other was shoplifting on average eight times daily. 
5.2.2   Number of Crimes Committed Per Client -Abstinent Clients
The mean number of crimes per client (n=39) was 3.3, the median and the
mode number of crimes was zero. The standard deviation was 15.1 and the
number of crimes ranged from zero to 90 crimes committed in the past 30
days. The total number of crimes committed by this cohort was 130 (16.5%)
in the past 30 days. 
5.2.3   Number of Crimes Committed Per Client -Clients 
Abstinent Excluding Alcohol 
The additional 7 clients in this cohort (n=46) who are abstinent excluding
alcohol, did not report any commission of crime. Thus the total number of
crimes committed by this cohort was again 130 (16.5%) in the past 30 days and
the number of crimes once more ranged from zero to 90. The mean number of
crimes per client was 2.83, the median and the mode number of crimes was zero.
The standard deviation was 13.9. 
5.2.4   Number of Crimes Committed Per Client by Gender
The mean number of crimes per male client (n=52) was 6.8, the median and
the mode number of crimes was zero. The standard deviation was 19.6 and the
number of crimes ranged from zero to 90 crimes committed in the past 30
days. The total number of crimes committed by this cohort was 354 in the past
30 days. 
The mean number of crimes per female client (n=17) was 11.4, the median
and the mode number of crimes was zero. The standard deviation was 46 and
the number of crimes ranged from zero to 190 crimes committed in the past
30 days. The total number of crimes committed by this cohort was 194 in the
past 30 days. In fact, 1 client committed 190 crimes, 4 clients committed 1
crime and the remainder did not commit any crimes. 
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5.3   Health & Risk Behaviour Results 
To derive a “health score”, clients are asked a number of questions about their
physical and psychological well-being. For each symptom out of a ten, they are
asked if, in the past 30 days, they have experienced it Always (=4), Often (=3),
Sometimes (=2), Rarely (=1) and Never (=0). These replies are each allocated a
numeric value and the sum of the values of the physical responses gives a
physical health score; the same applies to the psychological health indicators.
Lower scores indicate higher levels of wellbeing -a zero score means that a client
has never experienced any of the symptoms in the past 30 days, a score of 40
means that the client has experienced all of the symptoms all the time in the
past 30 days. 
Physical health measures are reported in Tables 14-16 and psychological health
measures are reported in Tables 17-19. Where more than one modal value exists,
the lowest is reported. 
5.3.1   Health
Table 14: Physical Health Scores 
Score Abstinent Non-Abstinent 
n=41 n=37
Mean 7.9 12.7 
Median 7 12 
Mode 7 9 
Standard Deviation 5.3 5.8 
Minimum 0 0
Maximum 21 26 
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Table 15: Physical Health Scores 
With respect to thoughts of suicide, 15 people (19%) reported thoughts of
ending their own life within the past 30 days; 8 people (10%) thought rarely of
ending their own life, of whom 3 were abstinent from all substances whilst the
other 5 were non-abstinent. 5 people (6.3%) reported that they sometimes had
thoughts of ending their own life, of whom all were non-abstinent and 2
people (2.5%) reported that they often had thoughts of ending their own life,
of whom 1 was abstinent from all substances excluding alcohol and the other
was non-abstinent.
Table 16: Physical Health Scores by Gender 
Score Abstinent Non-Abstinent
Excluding
Alcohol
n=46 n=32
Mean 7.7 13.8 
Median 7 13 
Mode 7 13 
Standard Deviation 5.2 5.3 
Minimum 0 3 
Maximum 21 26 
Score Male Female
n=50 n=18
Mean 9.9 11.8 
Median 9 11.5 
Mode 9 13 
Standard Deviation 6.3 5.4 
Minimum 0 4 
Maximum 26 24 
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Table 17: Psychological Health Scores 
Physically and psychologically, it appears that abstinent individuals are
reporting higher levels of wellbeing than those who are non-abstinent. Men
are reporting marginally better levels of wellbeing than women. It has been
observed that individuals not in treatment for drug use often have lower
health expectations [44] and thus post-treatment health scores may not reflect
improvement in general health and wellbeing. 
Table 18: Psychological Health Scores 
Score Abstinent Non-Abstinent
Excluding
Alcohol
n=46 n=32
Mean 12.5 17.9 
Median 13 17 
Mode 13 15 
Standard Deviation 7 7 
Minimum 0 6
Maximum 34 35 
Score Abstinent Non-Abstinent 
n=39 n=39
Mean 12.3 17.2 
Median 13 16 
Mode 14 12 
Standard Deviation 6.6 7.7 
Minimum 0 5 
Maximum 26 35 
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Table 19: Psychological Health Scores by Gender
Table 20 shows that many clients (n=71) are in contact with drug rehabilitation
and related services that they accessed subsequent to their time at Keltoi. 62
individuals (78%, n=79) were in contact with Keltoi aftercare services post-
discharge, 20 clients (25%) are still in touch with Keltoi one-to-one counselling
services and 9 clients (11.5%) report continued contact with Keltoi aftercare
services6. International research has pointed out that increased involvement and
engagement with services seems to assist in achieving better outcomes [10][48]. 
Table 20: In Contact with Services Accessed Since Keltoi 
5.3.2   Risk Behaviours 
Of the 29 clients (36%) who consumed substances other than cannabis and
alcohol in the past 30 days, 5 clients only (6%) reported injecting behaviour.
These clients were all using heroin, although all reported polydrug use. 2
clients (2.5%) injected daily twice a day, 1 client (1.3%) injected once on 1
day, 1 client (1.3%) twice on 2 days and 1 client (1.3%) injected once on
each of 4 days. 
___________________________
68 of the 9 clients reporting continued contact with Keltoi aftercare are receiving one-to-one
counselling. 
Score Male Female
n=50 n=18
Mean 14 16.7 
Median 13.5 17.5 
Mode 13 12 
Standard Deviation 7.8 7.7 
Minimum 0 3 
Maximum 35 34 
Contact with Services
% n
Yes 84 59 
No 16 12 
Total 100 71
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Sexual patrtners % n 
0 86 32 
1 11 4
2 3 1
Total 100 37
38 clients (47.5%) reported that they did not have contact with a regular
partner. Table 21 reports sexual contact results for these clients (n=37). Of the
5 clients who did not have a regular partner and who had sex without a
condom, the mean number of sexual partners was 4.2 (median = 3, mode = 3)
and the standard deviation was 3. The minimum was once and the maximum
was 9 times. 
Table 21: Sex Without a Condom
5.3.3   Deceased Clients 
Two clients are reported to have died before their interview took place. The
mortality rate over the two years of the study was thus 2.13% (2/94). However,
there is no record of these deaths with the General Mortality Register (GMR), or
relevant Coroners’ offices. 
Subsequent to the completion of their interview, three further participants are
reported to have died; one of these deaths has been officially verified, no record
of the other deaths has been identified. This corresponds to five deaths over a
three year period.
5.4   Social & Personal Contact Results 
From Table 22, entirely abstinent clients are reporting lower levels of contact
with partners, but both abstinent and non-abstinent clients have similar levels
of contact with relatives and friends. Table 23 shows that non-abstinent clients
have a greater number of contact days with their partner, where partner
indicates an individual with whom the client has an ongoing relationship. 
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Table 22: Social & Personal Contact
Table 23: Partner Contact Days
Table 24 indicates broadly similar levels of partner, relative and friend contact
for those clients who are abstinent excluding alcohol and those clients who
are non-abstinent. However, note that the median and modal values in each
column of Table 25 represent the full range of the distribution. 
28 male clients (54%) reported no contact with a partner in the past 30 days.
48 male clients (92%) reported contact with relatives and 46 male clients
(85%) reported contact with friends. 6 female clients (33.3%) reported no
contact with a partner in the past 30 days. 17 female clients (94%) reported
contact with relatives and 15 female clients (83%) reported contact with
friends. These results, in conjunction with Table 26 seem to indicate that
female clients in this cohort are more likely to have a regular partner and to
spend more time with their partner than male clients, but contact with
relatives and friends is similar for both groups. Note that the median and
modal values for each gender represent the full distribution. 
Abstinent     Non-Abstinent
n=41 n=39
% n % n
Had Partner Contact 46 19 59 23
Had Relatives Contact 93 38 95 37
Had Friends Contact 90 37 85 33
Days Abstinent     Non-Abstinent
n=41 n=39
Mean 12.7 16.4 
Median 0 26 
Mode 0 30 
Standard Deviation 14.4 14.7 
Minimum 0 0
Maximum 30 30 
21Keltoi Client Evaluation Study
Table 24: Social & Personal Contact 
Table 25: Partner Contact Days
Table 26: Partner Contact Days by Gender
Abstinent Non-Abstinent
Excluding
Alcohol
n=48 n=32
% n % n
Had Partner Contact 50 24 56 18
Had Relatives Contact 94 45 94 30
Had Friends Contact 90 43 84 27
Days Abstinent Non-Abstinent
Excluding
Alcohol
n=48 n=32
Mean 13.6 15.8 
Median 4.5 26 
Mode 0 30 
Standard Deviation 14.4 14.9 
Minimum 0 0 
Maximum 30 30 
Days Male Female
n=52 n=18
Mean 12.2 19.8 
Median 0 30 
Mode 0 30 
Standard Deviation 14.2 14.4 
Minimum 0 0
Maximum 30 30
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5.5   Employment Results 
Of the 40 clients (50%) who had paid work in the last 30 days, 23 individuals (57.5%)
did not miss any days work during that period while 8 of those individuals (20%)
reported that they were formally unemployed. 
9 individuals (11.25%) of the full cohort (n=80) did not report unemployment or paid
work in the last 30 days: 2 (2.5%) reported that they were on disability allowance, 2
(2.5%) reported that they were full-time students and 1 (1.25%) reported being in
training. 
Within the entirely abstinent cohort (n=41), 18 individuals (44%) had paid work in
the last 30 days while 17 individuals (42%) reported formal unemployment in the
same timeframe: 3 of those in paid work (17%) also reported formal unemployment
in that period. 13 individuals of this cohort (31.7%) worked 5 days a week/every day.
13 individuals (72%) of those who were in paid work did not miss any days due to
sickness or unauthorised absence. Table 27 shows a noticeable difference in mean and
median days with the non-abstinent group reporting higher levels of employment. 
Table 27: Days Employment 
`
Within the cohort that reported abstinence excluding alcohol (n=48), 24 individuals
(50%) had paid work in the last 30 days while 21 individuals (44%) reported formal
unemployment in the same timeframe: 3 of those in paid work (6.25%) also reported
formal unemployment in that period. 18 individuals of this cohort (37.5%) worked
5 days a week/every day. 16 individuals (67%) of those who were in paid work did
not miss any days due to sickness or unauthorised absence. Table 28 shows that there
is little difference in reported days of employment for the specified two groups. Tables
28-29 show that while formal unemployment results are similar for each gender,
male clients report higher mean and median days of paid work. It should be
noted that based on information from the Keltoi aftercare team, many former
clients are engaged in education and/or training. The MAP does not explicitly ask
about these activities, so formal data is not available.
Days Abstinent     Non-Abstinent
n=41 n=39
Mean 9.5 12.6 
Median 0 13 
Mode 0 0 
Standard Deviation 12.2 12.6 
Minimum 0 0 
Maximum 30 30 
23Keltoi Client Evaluation Study
Table 28: Days Employment
Table 29: Days Employment by Gender
6 Study Limitations 
It is a limitation of this study that no validation of the self-report interviews took place.
Although Keltoi did not carry out urinalysis to verify the self-reported results, research
has concluded that self-reporting tends to be reliable when no negative consequences
are incurred [39][14]. For reference, ROSIE results are not validated, DORIS results were
validated with the first 275 clients out of 1084 [55] and their results were in line with
the literature -86% concordance. NTORS also carried out validation using urinalysis
and achieved a concordance rate of 92%.  Furthermore, although the MAP is a self-
reporting instrument, it is well-validated and extensively field-tested [36]: validation  
Days Male Female
n=52 n=18
Mean 12.6 8.7 
Median 13 0 
Mode 0 0 
Standard Deviation 12.7 11.8 
Minimum 0 0 
Maximum 30 30
Days Abstinent Non-Abstinent
Excluding
Alcohol
n=48 n=32
Mean 11 11 
Median 1.5 0.5 
Mode 0 0 
Standard Deviation 12.4 12.8 
Minimum 0 0 
Maximum 30 30
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showed that the content of MAP was acceptable to clients and easily comprehended.
Results from the test-retest were highly acceptable and self-report validity was
confirmed by the high level of agreement with results of urinalysis in a sub-sample. As
the MAP was the research instrument of choice, its usefulness at baseline was limited
by the fact that clients have completed a detoxification prior to their admission to
Keltoi. Nonetheless, as a baseline interview was not conducted, longitudinal results are
not available for the key outcome measures of abstinence, criminal involvement,
general health, sexual behaviour, employment and social functioning. Thus the results
presented here cannot be considered in a “before and after” context; caution must be
exercised in drawing conclusions about if and how attendance at Keltoi influenced
outcomes. 
Table 30: Days Formal Unemployment by Gender
The design of the study does not permit reductions in problem behaviours to be
attributed directly to the impact of treatment factors. Keltoi did not use formal control
groups and participants were not randomly recruited. 
As this is not a longitudinal study, definitive results cannot be presented in relation to
changes in the drug and alcohol use of those who partook in the Keltoi programme.
This is therefore a field study to see if more in-depth evaluation of such programmes
is warranted. However, Keltoi clients generally share a common background of drug
misuse. Clients entering Keltoi are usually from the Irish opiate-addicted cohort, the
vast majority of whom have come through either detoxification units or residential
rehabilitation units, as these are the referral pathways for the Keltoi programme. More
than 50% of the sampled clients came from detoxification centres and thus are known
to fulfil heavy-dependence criteria and share common characteristics [51][52]. The
individuals sharing these characteristics have high relapse rates and present to
healthcare professionals with urgent treatment needs. That said, dependent drug use
is known to be a chronic, relapsing condition [38], therefore abstinence for any period
of time is a positive outcome that could be associated with attendance at  Keltoi.
Days Male Female
n=51 n=18
Mean 13.5 12.9 
Median 0 0 
Mode 0 0 
Standard Deviation 14.6 14.9 
Minimum 0 0
Maximum 30 30 
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Individual behavioural changes result from interactions of the person, their
environment and the intervention(s) that they experience. Each and all of
these may influence outcomes to a greater or lesser degree and this could not
be controlled for in this study. 
Other studies, including ROSIE, DORIS, and NTORS, collected baseline data
and measures were taken of behaviours for a 90 day pre-interview period,
rather than the 30 day pre-interview period used in this study. 
Per Table 1, this study successfully followed-up 85% of its cohort but would
have preferred that figure to be higher; however, the ROSIE abstinent cohort
achieved follow-up rates of 68% at 1-year. 
7 Literature Review
A literature review took place to establish what related work has already been
carried out and thus to contextualise this report in terms of the existing
international literature. Search words used for the online databases Medline,
PsycInfo and JSTOR were various combinations of “drug addiction, treatment,
outcomes, residential rehabilitation, abstinence” and “evaluation”. Very little
material was sourced using these keywords. Use was also made of the Health
Research Board’s (HRB) National Documentation Centre (NDC) and of
journals including Addiction, the Journal of Substance Abuse Treatment and Drug
and Alcohol Dependence.
It is clear firstly that, although there is a commitment to treatment evaluation
at a European level [18], published data on treatment outcome studies is not
widely available. It is also clear that there is a significant lack of consistency
in the methodology of the existing treatment outcome studies, which renders
results incomparable across studies and modalities, at a local, national and
international level. Studies may be cross-sectional or longitudinal, and have
vastly different sample sizes. Instrument validation does not always take place.
Although guidelines and sample evaluation instruments are available at
European level [17], the core research instruments vary in length and in the
measures examined, as well as in the pre-interview period measure and in
defining, for example, abstinence. Research questions are often similar yet
studies differ substantially in their data collection and analysis. It also seems
that studies at treatment centre or local level are not widely published, if they
have taken place at all. 
Table 31 briefly describes some characteristics of five major international
longitudinal prospective cohort studies -others exist, including VEdeTTE [54]
in Italy.
Some key results are described in further detail below, but it is important to
note that direct comparison between these studies and Keltoi is not possible
due to differences in the study parameters and data collection. Nonetheless, in
the absence of directly comparable research, some insight can be gained into
levels of abstinence obtained subsequent to treatment for drug misuse. 
7.1   Research Outcome Study in Ireland (ROSIE) 
82 individuals were recruited within the ROSIE abstinence modality, where
“abstinence modality” is defined as being in any structured programme which
required individuals to be drug-free (including free from any pharmacological
intervention) in order to participate in and remain on the programme1 . 68%
(n=56) successfully completed a 1-year interview [13] measuring a 90-day
preinterview period and 64% were in some form of treatment at 1-year. 
___________________________
1Six individuals were recruited to the ROSIE Study from Keltoi: it is not known if any of these
individuals were participants in both studies. 
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Table 31: Longitudinal Cohort Outcome Studies
Name ROSIE DORIS NTORS DATOS ATOS
Country Ireland Scotland UK USA Australia 
Start Year 2003 2000 1995 1990 2001 
Finish Year Ongoing Ongoing 2000 1997 2003 
Recruited 404 1007 1075 10010 825 
Cohort
Abstinence Alcohol & Alcohol & Substitute Undefined Undefined
Definition tobacco  tobacco  prescribed
Excludes medication,
alcohol & 
tobacco  
Pre-Interview 90 90 90 365 30
Days
Recruitment Yes Yes Yes Yes Yes
Across 
Modalities
Results by Yes No Yes Yes Yes
Modality
Longitudinal Yes Yes Yes Yes Yes
Cohort
Age Group Over 18 Unspecified Unspecified Unspecified Over 18 
Research Unvalidated Validated Validated Validated Validated
Instrument
Coverage National National National 11 cities 3 cities 
Payment €10 voucher Stg£10 Unspecified USA$10-15 A$30
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7.1.1   Key Results: Abstinence Modality 1-Year 
• 66% of participants completed their index abstinence-based treatment
programme. 
• 11% of individuals recruited within the abstinence modality were female. 
• Abstinence from all drugs (including prescribed methadone and excluding 
alcohol) was 41% at one year. 
• Levels of involvement in crime reduced across six of the twelve categories 
of offences. 
• Improvements were observed in nine out of the ten physical health
symptoms and five out of the ten mental health symptoms. 
• The mortality rate of the cohort was 1.2% (1/82). 
• 76% of participants reported no criminal involvement in the 90 days prior
to interview at 1-year.
• 20% of the cohort were injecting a drug at 1-year, a reduction of 10%. 
• Participants’ contact with social services increased from treatment intake. 
7.2   Drug Outcomes Research Study in Scotland (DORIS)
DORIS [40] is the largest survey of the effectiveness of drug misuse
treatment services ever carried out in Scotland. Results have been
published for all modalities at 33-month follow-up (90-day pre-
interview period), however, results are not available for the residential
rehabilitation cohort alone, nor are 1-year results available, thus it is
referenced here for completeness only. DORIS is careful to point out
that the study identifies an association between becoming drug-free
and different treatment modalities, rather than a causal explanation of
the route through which drug users in Scotland were able to become
drug free.
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7.3   National Treatment Outcome Research Study (NTORS) 
The UK NTORS has published 1-year [28] and 4-5 year [27] outcome results (90-
day pre-interview period) with 19% of the original cohort recruited from
residential settings. However, NTORS includes individuals using substitute
prescribed medication as abstinent. Once more, it is referenced for completeness
only. 
7.4   Drug Abuse Treatment Outcome Study (DATOS) 
DATOS [30][31] is the third US national multiprogram study, following the Drug
Abuse Reporting Program (DARP) [49] and the Treatment Outcome Prospective
Study (TOPS) [32]. 
DARP followed 4,017 individuals from a sample of 27,214 clients admitted to
treatment between 1969-1972, while TOPS followed 4,270 of 9,989 clients
admitted to treatment from 1979-1981. Both studies documented large
decreases in opioid use and criminal involvement after treatment. DATOS was
designed not only to enable replication of previous outcome studies but to
investigate emerging research and policy issues about treatment effectiveness.
Results are available for 1-year and 5-years, but abstinence of individuals is not
strictly defined; instead results are provided for cohort percentage using
particular drugs at 1-year. The pre-interview measure period varied from 90-days
to 1-year, depending on the question asked. The closest modality corresponding
to Keltoi is long-term residential (LTR) less than 3 months (sample size 213).
Results are published in terms of the % who participated in a given activity at
the 1-year interview; it is difficult to directly compare with Keltoi on this basis. 
7.4.1   Key Results: Long Term Residential (<3 months) 1-Year 
• Major reductions in most types of drug use were observed from baseline
(heroin: baseline = 17.2%, 1-year = 7.1%).
• Predatory illegal activity dropped by 20% approx. and sexual behaviour
risk dropped by 15% approx. 
• Increases in full-time employment were observed. 
• Health limitations decreased.
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7.5   Australian Treatment Outcome Study (ATOS) 
ATOS [15][53] reports a follow-up rate of 78% within the cohort of
participants recruited from residential rehabilitation. 
7.5.1   Key Results: All Modalities 1-Year
• 49% of the residential rehabilitation cohort were in some form of treatment
at 1-year.
• 63% of participants had not used heroin within 30-days pre-interview. 
• Substantial declines in heroin and other drug use were observed. 
• There were reductions in non-fatal heroin overdose and in needle risk
taking.
• Physical and mental health both improved subsequent to treatment. 
• Criminal activity decreased. 
7.6   Other Irish Studies
The Drug Misuse Research Division (DMRD) of the Health Research Board (HRB)
is the focal point for reporting to the European Monitoring Centre for Drugs and
Drug Addiction (EMCDDA). As such, it has been involved in a number of studies
related to the misuse of drugs, however, it has not been responsible for
evaluation of individual treatment centres and although organisations such as
Addiction Response Crumlin (ARC) [6] and Merchant’s Quay [7] have produced
evaluation reports of their activities, they are not producing treatment
evaluation outcome research. In fact, the Research Office of the Merchant’s
Quay Project Residential Programmes produced a report in 1999 on the Hyde
Park residential facility, which is based on the democratic therapeutic
community model. Key results were that 33% of programme participants were
female and that 42% (n=96) of those referred to the programme were admitted,
with 27% successfully completing the full programme. A pilot outcome research
study was scheduled to take place subsequent to that report, but results have not
been published. The National Advisory Council for Drugs (NACD) has recently
published a cross-community study on indicators for drug use [43], but ROSIE
[47] is its principal treatment outcome study to date. 
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It is clear that there is a gap in the existing Irish literature on treatment
outcome evaluation. This has been partly met by the two studies by Smyth et
al., one auditing the characteristics of clients presenting for treatment in Cuan
Dara in 1995-96 [51] and the other evaluating medium-term outcomes for
inpatient treatment of opiate dependence [52]. Despite differences in modality
and methodology, it is in the context of these works that Keltoi presents its
treatment evaluation outcome study.
7.7   Other Treatment Outcome Evaluation Studies 
The above studies and others have produced a wealth of literature on their
research findings. Topics include improvements in individuals’ physical and
mental health [31], reductions in drug use for certain modalities [27],
reductions in criminal behaviours [21], perceptions of drug treatment services
[19] and sustained contact with drug treatment services [48]. However, their
aim is not to evaluate specific treatment settings or modalities. Studies such as
that recently conducted in the UK “What happens to drug users when they
leave in-patient drug treatment?”, which follows up 100 clients from a
detoxification setting [37], are of more direct relevance. It must be noted
however that Keltoi is a unique treatment setting and a straight-forward “like-
with-like” comparison is not possible, not least because it is clear that causal
links between treatment and abstinence have yet to be established. 
8 Discussion
8.1   Comparison of the Keltoi Approach to Other Approaches 
The Keltoi approach was developed using evidence from a small number of
outcome studies on abstinence and rehabilitation of drug users and those who are
alcohol-dependent persons across the world, including Mesa Grande [42] and
Project Match [46]. Most of the studies were community-based. They all pointed
to a focus on drug misuse prevention and life skills training plus community
reinforcement-type models [50]. Earlier residential rehabilitation models often
emphasised a requirement to look in-depth at psychological and developmental
antecedents to drug use, in particular early traumatic environments and/or
experiences, whereby there is a “golden key” to unlock the door to the reasons for
substance misuse problems and once these are identified, recovery will follow.
Other models, such as the 12-step philosophy [2], emphasised mutual support and
the acceptance of a ready-made ideology; “off-the-peg”, “one-size-fits-all”
thinking about substance misuse. 
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Keltoi follows the more recent evidence cited above with a view to designing and
developing a programme that uses an individual skills-based approach to coping
with avoidance of drug use; the development of new coping skills and strategies
for living [11] that bring with them a rewarding lifestyle. 
Per Table 1, the Keltoi evaluation study successfully followed-up 85% of its cohort
but would have preferred that figure to be higher; however, the ROSIE abstinent
cohort achieved follow-up rates of 68% at 1-year. Of the 100 clients initially
recruited to the study, 77% completed the full Keltoi programme. 66% of the
ROSIE study participants completed their abstinence-based treatment programme.
It is important to note that of the 341 males and 141 females (n = 482) who
presented for assessment up to July 2004, attendance rates were very similar -31%
of males and 32% of females who presented for treatment were admitted to Keltoi.
ROSIE and DORIS define abstinence as abstinence from all drugs, including
prescribed substitute drugs, but excluding alcohol: this definition corresponds
to the Keltoi cohort results shown in Table 8. The Keltoi programme does not
necessarily advise all patients to desist from alcohol use. If a person has a light
social drinking pattern, they are warned of the possibility of cross-addiction to
alcohol but are not explicitly prohibited from continuing to use alcohol in
that way. Accordingly, 7 clients (9%) of the Keltoi cohort consumed alcohol
but did not report any other substance use in the 30-day pre-interview period.
• ROSIE reported 41% abstinence at 12 months for those recruited within
the abstinence modality.
• DORIS reported 8% abstinence at 33 months, but the analysis is across
modalities, in a different time-frame and not limited to those recruited in
a residential rehabilitation setting. 
NTORS defines abstinence as abstinence from all drugs excluding prescribed
substitute drugs and alcohol. However, it must be noted that studies including
ROSIE, DORIS, and NTORS took measures of behaviours for a 90-day
preinterview period, rather than the 30-day pre-interview period used in this
study.
With respect to the Keltoi cohort, it is clear from the risk behaviour results, the
psychological and physical health scores, as well as the crime results, that
those who are abstinent from all illicit drugs report better physical and
psychological health, less risk behaviour and less crime. Similar outcomes
associated with abstinence are reported in ROSIE, DORIS and NTORS. 
The ROSIE study [13] reported a mortality rate in its abstinence cohort of 1.2%
at one year. To our knowledge, the two year Keltoi study mortality rate stands
at 2.13% (2/94 individuals). 
A recent report issued by the Irish College of General Practitioners (ICGP) [8]
has identified male drug users as being at especially high risk of death; 75% of
those whose deaths were investigated as part of this report were men. Four
(80%) of those who are believed to have died before or after the Keltoi study
are men. A Dublin-based study published in 2006 makes it clear that at a
community level, it is strongly felt that drug-related deaths are under-reported
[43]
9 Conclusions & Recommendations 
9.1   Conclusions 
9.1.1   Outcomes for Treatment in Keltoi
6% of clients who applied to enter the treatment programme were not
accepted. This suggests that for those clients who meet the entry requirement
for Keltoi, the chances of commencing treatment are high. 
It is clear from the study results that the impact and outcomes for clients
attending Keltoi were positive. 51% of clients who undertook the treatment
programme were fully abstinent at the time of interview. 60% were abstinent
from all substances excluding alcohol in the same timeframe. Given the
known high relapse rates to chronic drug misuse, these results are
encouraging. 
There was a considerable reduction in risk and social harm behaviours for
those who were abstinent. For those who were not abstinent, only 6% of this
group reported injecting behaviour. Abstinent clients reported higher levels of
physical and psychological well-being. 
The sample of clients in Keltoi reflects the gender balance for clients within
the Irish services generally. Previous research indicates that women may be
less likely to take up residential treatment services, possibly because of
childcare issues. This was not the case for Keltoi’s client group. 
77% of the clients completed the treatment programme in its entirety. Such
high rates of completion are associated with greater likelihood of abstinence.
It demonstrates that clients felt the programme approach and components to
be relevant. This also demonstrates the programme’s value for money by
appropriate utilisation of Keltoi’s resources for clients. 
These figures suggest also that as a result of the treatment programme at
Keltoi, clients did not experience a negative impact on their drug-abuse and
risk-taking behaviour.
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9.1.2   Keltoi Outcomes Compared to Other Studies
Compared to a contemporaneous Irish study, treatment completion rates and
follow-up rates for this study are high. The completion rate of the ROSIE study
abstinent cohort was 66% compared to Keltoi’s 77%, while the follow-up rate
for the same ROSIE cohort was 68% compared to 85% in this study. Follow-up
data collected from clients in this study was robust. 
Abstinence rates achieved in this study were higher than those reported by the
ROSIE abstinent cohort, the closest comparator group. In the ROSIE study,
abstinence rates from all drugs (excluding alcohol) was 41% at 1-year. In the
Keltoi study, the equivalent rate was 60% for clients at 1-3 years. 
Given the reductions in drug use, social harm and risk behaviours, as well as
the health and psychological benefits that are reported by this study, we can
conclude, as other studies have demonstrated, that treatment achieving such
results is cost-effective [2] [27] [30]. 
The Keltoi programme was carefully designed around existing evidence in the
field. These key ingredients included prevention of drug use, the use of brief
interventions and addressing the social context (e.g. preparation for
community living) as well as the coping skills of the individual to prevent
relapse to drug misuse, a less adaptive coping mechanism, and linking with
community aftercare and aftercare from Keltoi counsellors for up to two years.
The results achieved in this study by this cohort help to generate a useful
hypothesis: “Are outcomes improved by the delivery of evidenced based
interventions within a residential setting where the focus is on creating a real-
life working context where clients can practice the living skills needed in the
community, with community follow-up?” 
9.2   Recommendations
This study has shown that little outcomes-based evaluation for treatment
programmes exists in Ireland and elsewhere[1]. More importantly, this lack of
both evaluation emphasis and outcome data limits the development of
strategic health policies for this area and limits the development of health
services research to maximise the efficiency and effectiveness of drug treatment
services (especially rehabilitation services). It is clear that a health-outcomes
focused monitoring-system should be introduced to all new and existing
clients within the drug treatment system and that regular data on outcomes
should be published by all services.  
Concomitantly, further outcomes data on rehabilitation services could serve to
raise awareness across the system on an efficient care-pathway to abstinent-
focused services. 
The data from this study indicates that there could be substantial benefits from
the treatment model ingredients, as outlined. To provide the best evidence on
what works with clients, it is necessary to undertake a controlled study to
compare the Keltoi model with other treatment approaches. This should be
done as a matter of priority, given the need to provide evidence-based care. 
The evidence from this and numerous other studies shows that significant
portions of clients in rehabilitation programmes do not achieve the desired
outcomes. As much as there is an obligation to discover what worked for
abstinent clients, it is equally necessary to understand what did not work with
the non-abstinent group of clients. Similarly, there is an immediate need to
understand how these clients could be re-engaged in treatment services.
Perhaps the coping skills training they accessed or received was not robust
enough [24]. 
Of particular concern is the mortality rate associated with this cohort: two
deaths within the follow-up period from November 2002 to July 2006 -a
period of just over 3.7 years. There have been reports of a further three deaths
(two unconfirmed) between November 2002 and November 2006: five deaths
over a four year period. Data on the causes of death for the majority of this
group are unavailable but it is clear that the Keltoi cohort, like similar cohorts
in substitute and other treatment modalities [56] [52], is not protected from
the harms of drug abuse and its ancillary health risks. Data collection on such
deaths needs to be tightened and more needs to be understood about the
circumstances surrounding the deaths of those who leave drug-treatment and
other related services. 
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Referral Procedures 
For best practice and to ensure that the prospective client makes an informed
choice, the Keltoi team strongly recommends that the referring agent visit Keltoi
in order to understand fully this unique programme. The referring agent, when
visiting their client, must be aware of the transparency of all meeting and
documentation, and most importantly, the partnership with the residential staff
in arranging a practical and workable discharge. 
Keltoi is unable to provide a holding period for clients who are awaiting
accommodation, nor is it able to facilitate referrals where mental health is the
main problem. However, residents with mental health problems who are in
remission or stabilised will be accepted. Admission must be voluntary and the
resident drug free, which includes being off methadone. This does not include
those on a psychotropic script, however, this will need to be negotiated with the
manager. Referrals made from in-patient facilities may transfer directly to Keltoi
upon completion of detoxification and assessments. 
Clients, if they request, can be referred from drug-treatment clinics first of all for
detoxification, and from there to Keltoi. Clients can also be referred by GPs,
community drug teams, the probation service, or they can even self-refer once
they are verifiably drug-free. Referrals made from out-patient facilities e.g.
community based programmes, must be drug free for two to six weeks depending
on the individual case and the assessment of the team. Each referral is
individually viewed and Keltoi staff will willingly work with referrers and clients
to establish an admission plan. A more detailed copy of the referral procedures
and polices for admission and stay at Keltoi are available upon request. 
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